Who We Are:
Technology has transformed almost every single aspect of our lives. Yet in biopharma, it still takes 12 years to develop a drug. Even today, thousands of diseases affecting hundreds of millions of people have no effective treatment. Accelerating the pace of bringing effective, new medicines to patients is one of the greatest opportunities for humanity. Our mission is to develop better drugs, faster using technology. We have built an end-to-end technology-driven drug discovery platform centered around one of the field’s largest human genomics databases in neuroscience. We use machine learning to map the complex causes of disease and turn those insights into promising drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat some of the biggest medical challenges today: ALS, Parkinson’s disease, and dementia. Our first drug entered the clinic in 2022 as a new treatment for ALS and was discovered entirely from our platform. We have raised $180M from top tier investors (e.g. BlackRock, Eli Lilly, Merck, Section 32, Threshold Ventures, Y Combinator, etc.). We are a team of engineers, neuroscientists, and drug developers united around an audacious vision: to build the next Genentech of the digital age.
Who You Are:
As the Vice President of Business Development, you will play a critical role in shaping the growth trajectory of Verge Genomics. Reporting to the Chief Business Officer (CBO), you will be responsible for driving strategic business initiatives, forging and managing partnerships, and identifying new market opportunities within the biotech sector. The ideal candidate will have 10-12 years of experience in business development, ideally within biotech or life sciences, with a deep understanding of industry trends, market dynamics, and regulatory landscapes.
This role requires a dynamic leader with a strong background in deal structuring, strategic planning, and relationship management to drive meaningful growth and long-term value for the company.